News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Orthofix settles foreign bribery charges. Cardiosolutions wins $8 million investment for mitral valve technology. OraSure plans $75 million stock offering. More news in brief.
You may also be interested in...
Regulatory News In Brief
Federal and state regulatory news updates.
Judge Weighs $42 Million Orthofix Settlement With Feds
Orthofix pleaded guilty to the felony of obstructing a federal audit and also has settled civil charges with the federal government. But the settlement will not be final until it is approved by a federal judge, who postponed his decision last week.
OraSure Preps October Launch Of First-Ever In-Home HIV Test
Firm gains PMA approval for OraQuick July 3, making it the first available HIV test that can be performed entirely in the home by untrained users.